APA (7th ed.) Citation

Renan Sukmawan, Erick Hoetama, Siska Suridanda Danny, Astuti Giantini, Erlin Listiyaningsih, Vidya Gilang Rejeki, . . . Isman Firdaus. (2021). Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Wiley.

Chicago Style (17th ed.) Citation

Renan Sukmawan, Erick Hoetama, Siska Suridanda Danny, Astuti Giantini, Erlin Listiyaningsih, Vidya Gilang Rejeki, Amir Aziz Alkatiri, and Isman Firdaus. Increase in the Risk of Clopidogrel Resistance and Consequent TIMI Flow Impairment by DNA Hypomethylation of CYP2C19 Gene in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (PPCI). Wiley, 2021.

MLA (9th ed.) Citation

Renan Sukmawan, et al. Increase in the Risk of Clopidogrel Resistance and Consequent TIMI Flow Impairment by DNA Hypomethylation of CYP2C19 Gene in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (PPCI). Wiley, 2021.